BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6444734)

  • 1. Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and the adenohypophysis to oestradiol: inhibition by L-thyroxine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(1):11-20. PubMed ID: 6444734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation oestradiol effects by silver nitrate: inhibition of the adenohypophyseal reaction, block of the ceruloplasmin increase and block of hypothalamic ascorbic acid depletion.
    Schreiber V; Pribyl T; Jahodová J
    Endokrinologie; 1980 Oct; 76(2):129-36. PubMed ID: 7449747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of the adenohypophyseal reaction to oestradiol: interaction of perphenazine with the thyroid hormones.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(2):173-9. PubMed ID: 6446099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interaction of oestrogen, testosterone and thyroid hormones on the serum ceruloplasmin level in rats.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; (2):129-37. PubMed ID: 140385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dopamine-beta-hydroxylase inhibitor (disulfiram) on the response of adenohypophysis, serum ceruloplasmin and hypothalamic ascorbic acid to estradiol treatment.
    Schreiber V; Pribyl T; Jahodová J
    Endocrinol Exp; 1979 Sep; 13(3):131-8. PubMed ID: 315864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between adenohypophyseal weight, serum polyphenol oxidase activity (ceruloplasmin) and hypothalamic ascorbic acid after estrogen treatment in rats.
    Schreiber V; Pribyl T; Jahodová J
    Horm Metab Res; 1980 Mar; 12(3):97-9. PubMed ID: 7372274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restitution of endocrine changes after discontinuing chronic oestradiol administration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1978; 27(6):505-13. PubMed ID: 152926
    [No Abstract]   [Full Text] [Related]  

  • 11. Metoclopramide potentiates the hypophyseal reactions to oestradiol.
    Schreiber V; Dusková J; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(5):385-9. PubMed ID: 6505072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the effect of oestradiol on adenohypophyseal weight: ineffectiveness of nickel chloride, potentiation by cimetidine.
    Schreiber V; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(1):11-6. PubMed ID: 6709725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1978; 27(4):301-7. PubMed ID: 151286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioestrogenic action of the aldosterone antagonist canrenoate K in the rat (adenohypophysis, ceruloplasmin).
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(5):385-95. PubMed ID: 144921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thyroxine binding to adenohypophysial proteins in vitro by 2,4-dinitrophenol administered in vivo.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1975; 24(2):147-56. PubMed ID: 124882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic control of adenohypophyseal growth.
    Schreiber V
    Vopr Biokhim Mozga; 1978; 13():221-7. PubMed ID: 756643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between the weight of adenohypophysis, thyroxine-binding adenohypophyseal proteins in vitro and level of ceruloplasmin in the rat serum: effect of hormones and of various neurotrophic drugs].
    Schreiber V
    Cesk Fysiol; 1976; 25(1):31-4. PubMed ID: 815007
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic antagonists potentiate the adenohypophyseal growth reaction to oestrogen: thioridazine is less effective than perphenazine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1987; 36(1):9-13. PubMed ID: 2884683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the antiestrogen Clomiphene on the reaction of the adenohypophysis to estradiol].
    Schreiber V; Pribyl T; Rohácová J
    Endokrinologie; 1972 Feb; 59(2):227-38. PubMed ID: 4624727
    [No Abstract]   [Full Text] [Related]  

  • 20. Interrelation between anterior pituitary weight and ceruloplasmin level in serum after estrogen administration in male rats.
    Schreiber V; Pribyl T
    Endocrinol Exp; 1976 Jun; 10(2):125-9. PubMed ID: 1084267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.